Oropharyngeal Carcinoma — Trials

Oropharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 107
Recruiting: 56
Ph III recruiting: 3
Growth YoY: −13.6%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07407205	Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer	active not recruiting	N/A	30	Institute of Oncology LjubljanaOTHER	1	Feb 17, 2026	clinicaltrials

Data updated 23 days agoSource updated Feb 17, 2026source: clinicaltrials